Our in vivo data showing coincident grem-1 overexpression with the development of renal damage, support the idea of GREMLIN as a key VEGFR2/ligand mediator of renal damage progression in diabetes [19,20]. This evidence concerns the gene GREM1 and diabetes mellitus.